---
title: "On 17 October 2026, the National Pharmaceutical Pricing Authority (NPPA) capped the trade margin on… — post — DecisionGateway"
description: "statement by post, recorded 2026-11-06 — verbatim quote and source citation."
canonical_url: "https://dgw.tmarket.io/claims/01a1df49-a4d0-7327-a3e3-43c226e39ce8"
meta:
  "og:description": "statement by post, recorded 2026-11-06 — verbatim quote and source citation."
  "og:image": "https://dgw.tmarket.io/og.jpg"
  "og:image:alt": "White network of connected nodes crossed by a timeline on black"
  "og:image:height": "1024"
  "og:image:width": "1024"
  "og:title": "On 17 October 2026, the National Pharmaceutical Pricing Authority (NPPA) capped the trade margin on… — post — DecisionGateway"
  "twitter:image": "https://dgw.tmarket.io/og.jpg"
---

> Index of every page on this site: [llms.txt](https://dgw.tmarket.io/llms.txt)

statementSaid on 2026-11-06

# **On 17 October 2026, the National Pharmaceutical Pricing Authority (NPPA) capped the trade margin on 137 non-scheduled anti-cancer medicines, including patented drugs, at 30% of the maximum retail price (MRP).**

A statement by post, said on 2026-11-06. Statements are as reported by the cited publishers — not verified by DecisionGateway.

> *30% व्यापार मार्जिन सीमा: 17 अक्टूबर, 2026 को राष्ट्रीय औषध मूल्य निर्धारण प्राधिकरण (एनपीपीए) ने पेटेंट प्राप्त दवाओं सहित 137 गैर-अनुसूचित कैंसर रोधी दवाओं पर व्यापार मार्जिन को अधिकतम खुदरा मूल्य (एमआरपी) के 30% तक सीमित कर दिया*

pib\_backgroundersPublished 2026-11-06 [ Read source](https://t.me/pib_backgrounders/764)

## **Discussion**

## **Related claims**

[**On 17 October 2026, the National Pharmaceutical Pricing Authority (NPPA) capped the trade margin on 137 anti-cancer non-scheduled medicines, including patented drugs, at 30% of the maximum retail price (MRP).**नेशनल फार्मास्युटिकल प्राइसिंग अथॉरिटी (NPPA) · statement](https://dgw.tmarket.io/claims/01a1df47-54bf-7072-a7e3-eb1cbe1e865d) [**On October 17, 2026, the National Pharmaceutical Pricing Authority (NPPA) capped the trade margin on 137 non-scheduled anti-cancer medicines, including patented ones, at 30% of the maximum retail price (MRP).**National Pharmaceutical Pricing Authority (NPPA) · statement](https://dgw.tmarket.io/claims/01a1df4e-8ed3-7d6c-979b-bf1a29df2ee5) [**On October 17, 2026, the National Pharmaceutical Pricing Authority (NPPA) capped the trade margin on 137 non-scheduled anti-cancer medicines, including patented ones, at 30% of the maximum retail price (MRP).**post author · statement](https://dgw.tmarket.io/claims/01a1df4d-5938-7c5d-b692-2e0e263fd55b) [**Estimated savings are ₹3,357.49 crore (as on November 4, 2026), with 70 companies reporting revised MRPs for 120 drugs.**post author · statement](https://dgw.tmarket.io/claims/01a1df4d-596c-77af-93e7-5aed5e9709df) [**As of 4 November 2026, 70 companies had announced revised MRPs for 120 medicines.**post · statement](https://dgw.tmarket.io/claims/01a1df49-a578-7af9-b0e7-9cac40d4bb68) [**Consumers can verify prices using both the NPPA website and the official Pharma Sahi Daam mobile app.**post · commitment](https://dgw.tmarket.io/claims/01a1df49-a5a8-7091-a0cb-5c059303ea63)

[All claims](https://dgw.tmarket.io/claims)

```json
{"@context":"https://schema.org","@graph":[{"@id":"https://dgw.tmarket.io/#website","@type":"WebSite","description":"Decisions, events and falsifiable forecasts from 4,500+ Telegram channels — every claim cited. Read free.","name":"DecisionGateway","url":"https://dgw.tmarket.io/","publisher":{"@id":"https://dgw.tmarket.io/#identity"}},{"@id":"https://dgw.tmarket.io/claims/01a1df49-a4d0-7327-a3e3-43c226e39ce8#webpage","@type":"WebPage","description":"statement by post, recorded 2026-11-06 — verbatim quote and source citation.","name":"On 17 October 2026, the National Pharmaceutical Pricing Authority (NPPA) capped the trade margin on… — post — DecisionGateway","url":"https://dgw.tmarket.io/claims/01a1df49-a4d0-7327-a3e3-43c226e39ce8","breadcrumb":{"@id":"https://dgw.tmarket.io/claims/01a1df49-a4d0-7327-a3e3-43c226e39ce8#breadcrumb"},"isPartOf":{"@id":"https://dgw.tmarket.io/#website"},"potentialAction":[{"@type":"ReadAction","target":["https://dgw.tmarket.io/claims/01a1df49-a4d0-7327-a3e3-43c226e39ce8"]}]},{"@id":"https://dgw.tmarket.io/#identity","@type":"Organization","name":"DecisionGateway","url":"https://dgw.tmarket.io"},{"@id":"https://dgw.tmarket.io/claims/01a1df49-a4d0-7327-a3e3-43c226e39ce8#breadcrumb","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","name":"Home","item":"https://dgw.tmarket.io","position":1},{"@type":"ListItem","name":"Claims","item":"https://dgw.tmarket.io/claims","position":2},{"@type":"ListItem","name":"On 17 October 2026, the National Pharmaceutical Pricing…","position":3}]},{"@id":"https://dgw.tmarket.io/claims/01a1df49-a4d0-7327-a3e3-43c226e39ce8#/schema/quotation/1","@type":"Quotation","dateCreated":"2026-11-06","isBasedOn":"https://t.me/pib_backgrounders/764","text":"30% व्यापार मार्जिन सीमा: 17 अक्टूबर, 2026 को राष्ट्रीय औषध मूल्य निर्धारण प्राधिकरण (एनपीपीए) ने पेटेंट प्राप्त दवाओं सहित 137 गैर-अनुसूचित कैंसर रोधी दवाओं पर व्यापार मार्जिन को अधिकतम खुदरा मूल्य (एमआरपी) के 30% तक सीमित कर दिया","url":"/claims/01a1df49-a4d0-7327-a3e3-43c226e39ce8"}]}
```

## Sitemap

See the full [sitemap](https://dgw.tmarket.io/sitemap.md) for all pages.
